Nvidias Market Cap Overtakes Germanys GDP Tech Giants Rival Top Economies Market Expert Sunil Subramaniam Suggests June Quarter Earnings as Key Driver for Market Direction Amid NearTerm Risks Anthropic Cofounder Chris Olah Warns Vatican on AI Job Losses Calls for Moral Oversight Sensex Nifty 50 Outlook Next Week Geopolitical Tensions from USIran Conflict May Influence Market Direction Standard Chartered to Reduce Corporate Functions Roles by Over 15 in Pursuit of Higher Returns US Productivity Growth Moderates in Fourth Quarter as Unit Labor Costs Rise Inotiv NOTV Q1 2026 Earnings EPS Falls Short Amid Operational Challenges STNE Q1 2026 Earnings EPS Misses Estimates by 391 Stock Edges Higher Nathans Famous Inc NATH Q4 2024 Earnings EPS of 096 Despite Quiet Quarter Stock Edges Lower QT Imaging Q1 2026 Earnings Wide EPS Miss and No Revenue Reported Weigh on Investor Sentiment TBBB Q1 2026 Earnings WiderThanExpected Loss Heightens Investor Concerns Aterian Inc ATER Q3 2025 Earnings Strong EPS Beat Highlights Operational Efficiency ATN International Holds Steady Modest Gains Amidst Key Support and Resistance Levels Baker Hughes BKR Faces Sharp Selloff Support Levels Under Pressure Blackrock MuniYield Quality Fund III MYI Gains 115 as Muni Bond Sentiment Improves Builders FirstSource BLDR Holds Steady Modest Gains Amid Housing Market Crosscurrents Renatus Tactical Acquisition Corp I Unit RTACU Hovers Near Key Support Amid Quiet Trading TMO Q1 2026 Earnings EPS Surpasses Estimates by 284 Stock Edges Down BLCO Q1 2026 Earnings EPS Surpasses Estimates by 365 Stock Declines 14 FSBW Q1 2026 Earnings Modest EPS Beat Highlights Stability Amid Soft Stock Response MDWD Q4 2025 Earnings NarrowerThanExpected Loss Offers Cautious Optimism Hope Bancorp HOPE Q1 2026 Earnings Modest EPS Beat Amidst Quiet Revenue Picture GRNT Q1 2026 Earnings Sharp EPS Miss Weighs on Investor Sentiment AIA Engineering Eyes Volume Growth Through New Mining Solutions Following Earnings Beat Inspira Technologies Q4 2023 Earnings Loss Narrows More Than Expected Amid RD Progress Fulcrum Therapeutics FULC Hovers Near Support After Marginal Uptick